The importance of p16 and CD117 expression in melanocytic lesions
Open Access
- 30 August 2021
- journal article
- research article
- Published by Adiyaman University in Adıyaman Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 7 (2) , 113-119
Abstract
Aim: The present study aims to determine the p16 and CD117 expression profiles of melanocytic lesions to investigate immune profiles that may facilitate differential diagnosis of melanoma from benign or potential precursor melanocytic lesions. Materials and Methods: Immunohistochemistry for p16 and CD117 was applied in a total of 81 cases with melanocytic lesions. Results: A significant loss of p16 expression was found in melanoma cases compared to benign and precursor melanocytic lesions (pppppp<0.01). Sonuç: p16 ve CD117 belirteçlerinin birlikte kullanıldığı zaman, melanomları benign lezyonlardan ve benign lezyonları potansiyel prekürsör melanositik lezyonlardan ayırımda önemli belirteçler olarak katkı sağlayacağını düşünmekteyiz.Keywords
Funding Information
- Araştırmanın destekleyicisi bulunmamaktadır
This publication has 30 references indexed in Scilit:
- The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesionsEuropean Journal of Histochemistry, 2011
- Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal typeLaboratory Investigation, 2009
- Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcomeBritish Journal of Cancer, 2009
- Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomasBritish Journal of Cancer, 2008
- KIT Gene Mutations and Copy Number in Melanoma SubtypesClinical Cancer Research, 2008
- Melanomagenesis: Overcoming the barrier of melanocyte senescenceCell Cycle, 2008
- The effect of the sun on expression of β-catenin, p16 and cyclin d1 proteins in melanocytic lesionsClinical and Experimental Dermatology, 2007
- L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibitionInternational Journal of Cancer, 2007
- Prevalence of KIT Expression in Human TumorsJournal of Clinical Oncology, 2004
- Adjuvant therapy in melanomaClinical and Experimental Dermatology, 2000